Sangamo Therapeutics: files Aug 2026 monthly operating report

What happened

• The filing says Sangamo Therapeutics, Inc. filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Code on Jun 23, 2026, commencing a Chapter 11 case styled In re Sangamo Therapeutics, Inc., case number 26-10989.
• The filing says that on Oct 14, 2026 the company filed with the United States Bankruptcy Court for the District of Delaware its monthly operating report for the period beginning Aug 1, 2026 and ended Aug 31, 2026.

Key details

• Chapter 11 petition filed on Jun 23, 2026; case number 26-10989; case styled In re Sangamo Therapeutics, Inc.
• Monthly operating report (MOR) filed with the Bankruptcy Court on Oct 14, 2026 for Aug 1, 2026 to Aug 31, 2026.
• The Form 8-K reports Item 7.01 (Regulation FD disclosure) and Item 9.01 (financial statements and exhibits).

Why it may matter

• Item 7.01 reports the company’s Chapter 11 case and the filing of its monthly operating report with the Bankruptcy Court; Item 9.01 notes the included exhibits.
• A filing does not show why the insider traded or why the company acted.